Hydroxypropyl-beta-cyclodextrin
Hydroxypropyl-beta-cyclodextrin (HPbCD) is a cyclodextrin derivative investigated as a therapeutic candidate for Niemann-Pick disease type C, receiving initial regulatory approval in 2009. Its application extends to in vitro and in vivo research for solubilizing compounds and mobilizing cholesterol in cellular models.
Product Specifications
CAS Number
107745-73-3
Field of Research
Infectious Disease & Virology
Smiles
[H][C@@]12O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]3 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]4 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]5 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]6 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]7 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O[C@@]8 ([H]) O[C@H] (COCC (C) O) [C@@] ([H]) (O1) [C@H] (O) [C@H]8O) [C@H] (O) [C@H]7O) [C@H] (O) [C@H]6O) [C@H] (O) [C@H]5O) [C@H] (O) [C@H]4O) [C@H] (O) [C@H]3O) [C@H] (O) C2O
Molecular Formula
C63H112O42
Molecular Weight
1541.547
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog